545P Preclinical profile of EPI-7386, a second-generation N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer

Autor: Le Moigne, R., Hong, N.H., Pearson, P., Lauriault, V., Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Virsik, P., Andersen, R.J., Sadar, M.D., Zhou, H-J., Cesano, A.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S475-S475
Databáze: ScienceDirect